Dergiler / Turkish Journal of Chemistry / 2014 / Cilt: 38 - Sayı: 1

Synthesis and antimicrobial activity of novel 2-[4-(1H-benzimidazol-1-yl)phenyl]-1H-benzimidazoles

Sayfa
152–156
Yayın Tarihi
2014-05-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Compounds 13, 15, 18, 20, and 21 have moderate antifungal activity against C. albicans.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:A new class of 2-[4-(1H-benzimidazol-1-yl)phenyl]-1H-benzimidazoles (13--22) were synthesized via cyclocondensation reaction of the substituted 1,2-phenylenediamines (1, 4--12) and 1-(4-formylpheny)-1H-benzimidazole (3).
📊
Temel Bulgular & Veri:The synthesized compounds were evaluated for antibacterial and antifungal activities against S. aureus, methicillin-resistant Staphylococcus aureus (MRSA), and Candida albicans by the tube dilution method.
💡
Sonuç & Katkı:Compounds 13, 15, 18, 20, and 21 have moderate antifungal activity against C. albicans.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:1H-Benzimidazole · antimicrobial activities · methicillin resistant Staphylococcus aureus

Özet

A new class of 2-[4-(1H-benzimidazol-1-yl)phenyl]-1H-benzimidazoles (13--22) were synthesized via cyclocondensation reaction of the substituted 1,2-phenylenediamines (1, 4--12) and 1-(4-formylpheny)-1H-benzimidazole (3). The synthesized compounds were evaluated for antibacterial and antifungal activities against S. aureus, methicillin-resistant Staphylococcus aureus (MRSA), and Candida albicans by the tube dilution method. Compounds 13, 15, 18, 20, and 21 have moderate antifungal activity against C. albicans.

Abstract

A new class of 2-[4-(1H-benzimidazol-1-yl)phenyl]-1H-benzimidazoles (13--22) were synthesized via cyclocondensation reaction of the substituted 1,2-phenylenediamines (1, 4--12) and 1-(4-formylpheny)-1H-benzimidazole (3). The synthesized compounds were evaluated for antibacterial and antifungal activities against S. aureus, methicillin-resistant Staphylococcus aureus (MRSA), and Candida albicans by the tube dilution method. Compounds 13, 15, 18, 20, and 21 have moderate antifungal activity against C. albicans.

🔖

Bu Makaleye Atıf Yap

ALP, M., GÖKER, A. H., ALTANLAR, N. (2014). Synthesis and antimicrobial activity of novel 2-[4-(1H-benzimidazol-1-yl)phenyl]-1H-benzimidazoles. Turkish Journal of Chemistry, Cilt: 38 - Sayı: 1, 152–156. https://ajindex.com/articles/184720

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. Stefani, S.; Chung, D. R.; Lindsay, J. A.; Friedrich, A. W.; Kearns, A. M.; Westh, H.; MacKenzie, F. M. Int. J. Antimicrob. Ag. 2012, 39, 273–282.
  2. Cheng, T.-J. R.; Wu, Y.-T; Yang, S.-T.; Lo, K.-H.; Chen, S.-K.; Chen, Y.-H.; Huang, W.-I.; Yuan, C.-H.; Guo, C.-W.; Huang, L.-Y.; et al. Bioorg. Med. Chem. 2010, 18, 8512–8529.
  3. Alp, M.; G¨ oker, H.; Brun, R.; Yıldız, S. Eur. J. Med. Chem. 2009, 44, 2002–2008. G¨ oker, H.; Kus, C.; Boykin, D. W.; Yıldız, S.; Altanlar, N. Bioorg. Med. Chem. 2002, 10, 2589–2596. G¨ oker, H.; Alp, M.; Ates-Alag¨ oz, Z.; Yıldız, S. J. Heterocyclic Chem. 2009, 46, 936–948.
  4. Puskullu, M. O.; Yıldız, S.; G¨ oker, H. Arch. Pharm. Chem. Life Sci. 2010, 343, 31–39. National Committee for Clinical Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Fifth Edition, 17(2), Approve Standard, M7-A5, Wayne, PA, USA, 2000.
  5. Shadomy, S.; Pfaller, M. A. Laboratory Studies with Antifungal Agents: Susceptibility Tests and Quantitation in Body Fluids. In: Balows, A.; Hausler, W. J.; Hermann, K. L.; Isenberg, H. D.; Shadomy, H. J.; Eds. Manual of Clinical Microbiology, 5th Ed., American Society of Microbiology, Washington DC, USA, 1991, Chapter 117, p. 11 Furniss, B. S.; Hannaford, A. J.; Smith, P. W.; Tatchell, A. R. Vogel’s Textbook of Practical Organic Chemistry, 5th Edition, Longman Scientific & Technical: UK, 1989, pp. 1162–1163.
  6. Sircar, I.; Duell, B. L.; Bristol, J. A.; Weishaar, R. E.; Evans, D. B. J. Med. Chem. 1987, 30, 1023–1029.
  7. Kucukbay, H.; Durmaz, R.; Sireci, N; Gunal, S. Asian J. Chem. 2010, 22, 2816–2824. S ¸ireci, N.; K¨ u¸ c¨ ukbay, H.; Akkurt, M.; Yal¸ cın, S ¸. P.; Tahir, M. N.; Ott, H. J. Coord. Chem. 2010, 63, 3218–3228. ¨ Ozden, S.; Usta, F.; Altanlar, N.; G¨ oker, H. J. Heterocyclic Chem. 2011, 48, 1317–1322.
  8. Ridley, H. F.; Spickett, R. G. W.; Timmis, G. M. J. Heterocyclic Chem. 1965, 2, 453–456.